doi: 10.3389/fpsyt.2025.1626103 Received 13 May 2025 Accepted 27 October 2025 Published 17 November 2025 Volume 16 - 2025 Edited by Luciane Cruz Lopes, University of Sorocaba, Brazil Reviewed by Raffaele Carraro, La Princesa University Hospital, Spain Kyle Valentino, University of Toronto, Canada Updates Copyright 2025 Yu, Huang, Lo, Huang, Yang and Kornelius
The higher the C rating, the cooler the pack should run, and the longer it should therefor last as was covered on the RC LiPo Page in the discharge section
Reported or proposed issue Pregnancy, breastfeeding, children, liver disease, or cancer history Evidence source No direct human safety data Known or theoretical
GLP-1 medications are a powerful tool, but not a standalone solution GLP-1 receptor agonists are an exciting advancement in obesity treatment
Product specifications, pricing, promotional offers, shipping policies, cancellation and refund terms, contact information, regulatory status, and customer feedback data may change after publication without notice